AORT
Artivion, Inc.$25.45+0.49 (+1.98%)Prev Close$24.97·MCap$1.22B·P/E107.38·Vol615.4K·Yield0.00%
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
40
$18.75M
◆
Net Activity
Net Seller
$18.75M
●
Active Insiders
8
last 12 mo
Over the past 12 months, insider activity at Artivion, Inc. (AORT) has been exclusively selling, with 0 insider purchases totaling $0.00 and 40 insider sales totaling $18.75M. The most recent insider transaction was by GREEN ANDREW M (officer: SVP, Regulatory and Quality), who sold $286.7K worth of shares on Sep 11, 2026. Artivion, Inc. operates in the Healthcare sector, within the Medical - Devices industry, with a market cap of $1.22B.
AORT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 11,480 | $24.97 | $286.7K | 40,160 |
| Sep 4, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 8,003 | $27.03 | $216.3K | 53,133 |
| Aug 20, 2026 | Mackin James P | officer: President & CEO | Sell | 70,000 | $28.96 | $2.03M | 877,275 |
| Aug 17, 2026 | Berry Lance A | officer: EVP, COO, CFO & Treasurer | Sell | 715 | $28.55 | $20.4K | 210,112 |
| Aug 17, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 616 | $28.55 | $17.6K | 59,643 |
| Aug 12, 2026 | Holloway Jean F | officer: SVP, General Counsel | Sell | 977 | $28.49 | $27.8K | 184,118 |
| Jun 15, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 44,001 | $20.70 | $910.7K | 60,259-42% |
| Mar 3, 2026 | Berry Lance A | officer: EVP, COO, CFO & Treasurer | Sell | 5,178 | $38.02 | $196.9K | 176,269 |
| Mar 3, 2026 | Davis John E | officer: Chief Commercial Officer | Sell | 2,784 | $38.02 | $105.9K | 206,522 |
| Mar 3, 2026 | Holloway Jean F | officer: SVP, General Counsel | Sell | 2,183 | $38.02 | $83.0K | 170,105 |
| Mar 3, 2026 | Horton Amy | officer: VP, Chief Accounting Officer | Sell | 641 | $38.02 | $24.4K | 132,514 |
| Mar 3, 2026 | Mackin James P | officer: President & CEO | Sell | 14,911 | $38.02 | $567.0K | 848,214 |
| Mar 3, 2026 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | Sell | 1,513 | $38.02 | $57.5K | 40,408 |
| Feb 25, 2026 | Berry Lance A | officer: EVP, COO, CFO & Treasurer | Sell | 9,466 | $36.69 | $347.3K | 148,450 |
| Feb 25, 2026 | Davis John E | officer: Chief Commercial Officer | Sell | 5,848 | $36.92 | $215.9K | 190,943 |
| Feb 25, 2026 | Holloway Jean F | officer: SVP, General Counsel | Sell | 4,747 | $36.92 | $175.3K | 153,871 |
| Feb 25, 2026 | Horton Amy | officer: VP, Chief Accounting Officer | Sell | 2,561 | $36.97 | $94.7K | 128,327 |
| Feb 25, 2026 | Mackin James P | officer: President & CEO | Sell | 34,898 | $36.83 | $1.29M | 780,031 |
| Feb 25, 2026 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | Sell | 3,682 | $36.94 | $136.0K | 43,180 |
| Dec 15, 2025 | Davis John E | Chief Commercial Officer | Sell | 5,000 | $45.11 | $225.6K | 0 |
| Dec 8, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 4,572 | $44.42 | $203.1K | 0 |
| Dec 3, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 7,315 | $45.30 | $331.4K | 0 |
| Dec 3, 2025 | Mackin James P | President & CEO | Sell | 30,921 | $45.46 | $1.41M | 0 |
| Dec 2, 2025 | Mackin James P | President & CEO | Sell | 30,921 | $45.56 | $1.41M | 0 |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 47,376 | $45.04 | $2.13M | 0 |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 15,276 | $44.18 | $674.8K | 0 |
| Nov 18, 2025 | Hoff Elizabeth A | Director | Sell | 4,200 | $45.10 | $189.4K | 0 |
| Nov 17, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 6,000 | $45.73 | $274.4K | 0 |
| Nov 14, 2025 | Davis John E | Chief Commercial Officer | Sell | 6,393 | $44.67 | $285.6K | 0 |
| Nov 14, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 12,787 | $45.09 | $576.5K | 0 |
| Nov 13, 2025 | Davis John E | Chief Commercial Officer | Sell | 6,563 | $45.86 | $301.0K | 0 |
| Nov 13, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 5,761 | $45.86 | $264.2K | 0 |
| Nov 13, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 3,482 | $45.86 | $159.7K | 0 |
| Nov 13, 2025 | Mackin James P | President & CEO | Sell | 34,210 | $45.86 | $1.57M | 0 |
| Nov 13, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 4,993 | $45.86 | $229.0K | 0 |
| Nov 10, 2025 | Davis John E | Chief Commercial Officer | Sell | 3,373 | $44.62 | $150.5K | 0 |
| Nov 10, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 12,960 | $45.82 | $593.9K | 0 |
| Nov 10, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 1,789 | $44.62 | $79.8K | 0 |
| Nov 10, 2025 | Mackin James P | President & CEO | Sell | 17,580 | $44.62 | $784.4K | 0 |
| Nov 10, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2,566 | $44.62 | $114.5K | 0 |
| Aug 27, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 18,200 | $44.02 | $801.2K | 0 |
| Aug 25, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 10,000 | $44.37 | $443.7K | 0 |
| Aug 15, 2025 | Mackin James P | President & CEO | Sell | 12,500 | $42.32 | $529.0K | 0 |
| Aug 12, 2025 | Davis John E | Chief Commercial Officer | Sell | 10,802 | $43.67 | $471.8K | 0 |
| Aug 12, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 23,356 | $43.01 | $1.00M | 0 |
| Aug 8, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 7,992 | $38.49 | $307.6K | 0 |
| Jun 17, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 15,000 | $29.50 | $442.5K | 0 |
| Jun 13, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 26,132 | $28.44 | $743.1K | 0 |
| May 27, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 8,748 | $29.00 | $253.7K | 0 |
| May 23, 2025 | SEMEDO ANTHONY B. | Director | Sell | 2,600 | $28.47 | $74.0K | 0 |
Showing 1–50 of 223
1 / 5
AORT Insider Buying Activity
The following table shows recent insider purchases of Artivion, Inc. (AORT) stock reported via SEC Form 4 filings.
No insider buying activity found for AORT in the last 12 months.
AORT Insider Selling Activity
The following table shows recent insider sales of Artivion, Inc. (AORT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Sep 11, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 11,480 | $24.97 | $286.7K | 40,160 |
| Sep 4, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 8,003 | $27.03 | $216.3K | 53,133 |
| Aug 20, 2026 | Mackin James P | officer: President & CEO | Sell | 70,000 | $28.96 | $2.03M | 877,275 |
| Aug 17, 2026 | Berry Lance A | officer: EVP, COO, CFO & Treasurer | Sell | 715 | $28.55 | $20.4K | 210,112 |
| Aug 17, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 616 | $28.55 | $17.6K | 59,643 |
| Aug 12, 2026 | Holloway Jean F | officer: SVP, General Counsel | Sell | 977 | $28.49 | $27.8K | 184,118 |
| Jun 15, 2026 | GREEN ANDREW M | officer: SVP, Regulatory and Quality | Sell | 44,001 | $20.70 | $910.7K | 60,259-42% |
| Mar 3, 2026 | Berry Lance A | officer: EVP, COO, CFO & Treasurer | Sell | 5,178 | $38.02 | $196.9K | 176,269 |
| Mar 3, 2026 | Davis John E | officer: Chief Commercial Officer | Sell | 2,784 | $38.02 | $105.9K | 206,522 |
| Mar 3, 2026 | Holloway Jean F | officer: SVP, General Counsel | Sell | 2,183 | $38.02 | $83.0K | 170,105 |
| Mar 3, 2026 | Horton Amy | officer: VP, Chief Accounting Officer | Sell | 641 | $38.02 | $24.4K | 132,514 |
| Mar 3, 2026 | Mackin James P | officer: President & CEO | Sell | 14,911 | $38.02 | $567.0K | 848,214 |
| Mar 3, 2026 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | Sell | 1,513 | $38.02 | $57.5K | 40,408 |
| Feb 25, 2026 | Berry Lance A | officer: EVP, COO, CFO & Treasurer | Sell | 9,466 | $36.69 | $347.3K | 148,450 |
| Feb 25, 2026 | Davis John E | officer: Chief Commercial Officer | Sell | 5,848 | $36.92 | $215.9K | 190,943 |
| Feb 25, 2026 | Holloway Jean F | officer: SVP, General Counsel | Sell | 4,747 | $36.92 | $175.3K | 153,871 |
| Feb 25, 2026 | Horton Amy | officer: VP, Chief Accounting Officer | Sell | 2,561 | $36.97 | $94.7K | 128,327 |
| Feb 25, 2026 | Mackin James P | officer: President & CEO | Sell | 34,898 | $36.83 | $1.29M | 780,031 |
| Feb 25, 2026 | Stanton Marshall S. | officer: SVP, Clinical & MD Affair | Sell | 3,682 | $36.94 | $136.0K | 43,180 |
| Dec 15, 2025 | Davis John E | Chief Commercial Officer | Sell | 5,000 | $45.11 | $225.6K | 0 |
| Dec 8, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 4,572 | $44.42 | $203.1K | 0 |
| Dec 3, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 7,315 | $45.30 | $331.4K | 0 |
| Dec 3, 2025 | Mackin James P | President & CEO | Sell | 30,921 | $45.46 | $1.41M | 0 |
| Dec 2, 2025 | Mackin James P | President & CEO | Sell | 30,921 | $45.56 | $1.41M | 0 |
| Nov 21, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 47,376 | $45.04 | $2.13M | 0 |
| Nov 20, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 15,276 | $44.18 | $674.8K | 0 |
| Nov 18, 2025 | Hoff Elizabeth A | Director | Sell | 4,200 | $45.10 | $189.4K | 0 |
| Nov 17, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 6,000 | $45.73 | $274.4K | 0 |
| Nov 14, 2025 | Davis John E | Chief Commercial Officer | Sell | 6,393 | $44.67 | $285.6K | 0 |
| Nov 14, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 12,787 | $45.09 | $576.5K | 0 |
| Nov 13, 2025 | Davis John E | Chief Commercial Officer | Sell | 6,563 | $45.86 | $301.0K | 0 |
| Nov 13, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 5,761 | $45.86 | $264.2K | 0 |
| Nov 13, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 3,482 | $45.86 | $159.7K | 0 |
| Nov 13, 2025 | Mackin James P | President & CEO | Sell | 34,210 | $45.86 | $1.57M | 0 |
| Nov 13, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 4,993 | $45.86 | $229.0K | 0 |
| Nov 10, 2025 | Davis John E | Chief Commercial Officer | Sell | 3,373 | $44.62 | $150.5K | 0 |
| Nov 10, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 12,960 | $45.82 | $593.9K | 0 |
| Nov 10, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 1,789 | $44.62 | $79.8K | 0 |
| Nov 10, 2025 | Mackin James P | President & CEO | Sell | 17,580 | $44.62 | $784.4K | 0 |
| Nov 10, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 2,566 | $44.62 | $114.5K | 0 |
| Aug 27, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 18,200 | $44.02 | $801.2K | 0 |
| Aug 25, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 10,000 | $44.37 | $443.7K | 0 |
| Aug 15, 2025 | Mackin James P | President & CEO | Sell | 12,500 | $42.32 | $529.0K | 0 |
| Aug 12, 2025 | Davis John E | Chief Commercial Officer | Sell | 10,802 | $43.67 | $471.8K | 0 |
| Aug 12, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 23,356 | $43.01 | $1.00M | 0 |
| Aug 8, 2025 | Horton Amy | VP, Chief Accounting Officer | Sell | 7,992 | $38.49 | $307.6K | 0 |
| Jun 17, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 15,000 | $29.50 | $442.5K | 0 |
| Jun 13, 2025 | Stanton Marshall S. | SVP, Clinical & MD Affair | Sell | 26,132 | $28.44 | $743.1K | 0 |
| May 27, 2025 | Holloway Jean F | SVP, General Counsel | Sell | 8,748 | $29.00 | $253.7K | 0 |
| May 23, 2025 | SEMEDO ANTHONY B. | Director | Sell | 2,600 | $28.47 | $74.0K | 0 |
AORT Insiders
Similar Stocks to AORT
SYK
Stryker Corporation
$281.11-0.32%
$105.57B
BSX
Boston Scientific Corporation
$43.93-2.48%
$66.83B
EW
Edwards Lifesciences Corporation
$85.82+0.33%
$49.62B
DXCM
DexCom, Inc.
$86.69+2.37%
$31.33B
ZBH
Zimmer Biomet Holdings, Inc.
$99.10+2.61%
$18.09B
GMED
Globus Medical, Inc.
$74.78-1.29%
$10.01B
GKOS
Glaukos Corporation
$172.13+0.61%
$9.87B
PODD
Insulet Corp.
$139.63+1.32%
$9.14B